A new Affordable Care Act initiative from HHS will better coordinate cancer care with the intention of improving the quality of care provided and reducing the money spent on healthcare, according to an announcement from HHS.
A new Affordable Care Act initiative from HHS will better coordinate cancer care with the intention of improving the quality of care provided and reducing the money spent on healthcare, according to an announcement from HHS.
Cancer cost the United States an estimated $263.8 billion in medical costs and lost productivity in 2010, with the majority of patients who are diagnosed older than 65 years and Medicare beneficiaries. The Oncology Care Model was developed by the CMS Innovation Center through feedback from the oncology community, patient advocates, and the private sector.
“We aim to provide Medicare beneficiaries struggling with cancer with high-quality care around the clock and to reward doctors for the value, not volume, of care they provide. Improving the way we pay providers and deliver care to patients will result in healthier people,” Patrick Conway, MD, CMS chief medical officer and deputy administrator for innovation and quality, said in a statement.
CMS will invest in physician-led practices and allow them to innovate and delivery higher-quality care and is seeking participation of other payers. The model will provide episode-based, performance-based payments that incentivize high-quality, coordinated care. Practices that participate in the Oncology Care Model will receive monthly care management payments for each Medicare fee-for-service beneficiary during an episode.
The model will focus on 3 key areas: linking payment to quality of care; improving and innovating care delivery; and sharing information more broadly to providers, consumers, and others to support better decision while maintaining privacy.
“With the Oncology Care Model, CMS has the opportunity to achieve 3 goals in the care of this medically complex population who are facing a cancer diagnosis: better care, smarter spending, and healthier people,” Dr Conway said. “As a practicing physician and son of a Medicare beneficiary who died from cancer, I know the importance of well-coordinated care focused on the patient’s needs.”
More information about the Oncology Care Model will be available through a webinar from the CMS Innovation Center on February 19.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More